Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects:

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects:

Frequency of tobacco smoking among smokers. by Prasanna Herath (20714794)

Subjects:

Correlation of lung function parameters with smoking variables. by Prasanna Herath (20714794)

Subjects:

Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

Subjects:

Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Enterocolitis severity increases with DSS concentration. by Cuilee Sha (4836888)

Characteristics of HACE respondents by year. by David Henderson (4612354)

“…Satisfaction was lower in patients living in more deprived areas at all time points, and the gap between the most and least deprived populations widened over time, with the RII increasing from 1.05 (95% CI 1.04–1.06) in 2011/12 to 1.12 (95% CI 1.08–1.15) in 2021/22. …”

S2 Appendix - by Shaaista Budhani (21030221)

Outcomes and interventions by group comparison. by Shaaista Budhani (21030221)

S1 Fig.pdf - by Shaaista Budhani (21030221)

Baseline characteristics of participants. by Shaaista Budhani (21030221)